Comorbidity of Autoimmune Diseases: a Field that Needs Multidisciplinary Attention

CUI Bei-bei, XIE Qi-bing, YIN Geng

Abstract

Comorbidity of autoimmune diseases is a very important issue but easily ignored in the clinical practice. The treatment of comorbidity of autoimmune diseases needs cooperation of multiple disciplines, which is totally different from traditional clinical disciplines division and treatment mode. Based on the clinical features of the disease, we will comprehensively look through genetic, environmental, and immune factors involving in molecular and immunological compatibility pathogenesis, and also generalize common pathological features, such as immune complex deposition and accumulation of lymphocytes. We will also investigate the association and differences between the diseases with comorbidity, and explore the outcome and prognosis of comorbidity of autoimmune diseases. With clarify of the concept of autoimmune comorbidities, we hope bring more and more attention on this aspect, so as to improve the diagnosis, treatments as well as the prognosis of these diseases.

 

Keywords: Autoimmune diseases, Comorbidity, Pathogenesis, General practice 

 

Full Text:

PDF


References


VALERIE К, ANNE-SOPHIE К. VERONIQUE D. et al. Organ-specific disease provoked by systemic autoimmunity. Cell,1996,87(5);811-822.

THORSBY K. LIE B. HLA associated genetic predisposition to autoimmune diseases; genes involved and possible mechanisms. Transpl Immunol,2005,14(3/4): 175-182.

GORODEZKY C, ALAEZ C, MURGUIA A, et al. HLA and autoimmune diseases; type 1 diabetes (T1D) as an example. Autoimmun Rev,2006,5(3); 187-194.

KORZENIOWSKA-KOWAL A, WITKOWSKAL D. GARMIAN A. Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases. Postepy Hig Med Dos, 2001 . 55(2); 211-232.

OBREGON C, KUMAR R, PASCUAL M, et al. Update on dendritic cell-induced immunological and clinical tolerance. Front Immunol, 2017, 20 ( 8): 1514 [2017-12-05]. doi; 10. 3389/fimmu. 2017. 01514. https://www. ncbi. nlm. nib. gov/ pubmed ? term = Dendritic-hCell-Induced + Immunological + and + Clinical-Ь Tolerance.

MESQUITA D. KIRSZTAJN G, FRANCO M. et al. CD4+ T helper cells and regulatory T cells in active lupus nephritis; an imbalance towards a predominant ТЫ response? Clin Exp Immunol ,2018.191(1); 50-59.

SOZZANI S. DEL-PRETE A, BOSISIO D. Dendritic cell recruitment and activation in autoimmunity. J Autoimmun. 2017, 85: 126-140 [ 2017-12-05 ]. https://linkinghub. elsevier. com/retrieve/pii/S0896-8411 ( 17) 30502-4. doi; 10. 1016/j. jaut. 2017.07.012.

ZHOU H. WU L. The development and function of dendritic cell populations and their regulation by miRNAs. Protein Cell,2017,8(7);501-513.

FRIDKIS-HARELI M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis, 2008, 5; 1 [ 2017-12-05 ]. https j / / www. ncbi. nlm. nib. gov/pmc/articles/pmid/ 18275618/. doi; 10. 1186/1740-2557-5-1.

JARYAL A, VIKRANT S. Current status of lupus nephritis. Indian J Med Res,2017,145(2); 167-178.

GOULESAV, KAPSOGEORGOU EK, TZIOUFAS AG. Insight into pathogenesis of Sjogren’s syndrome; dissection on autoimmune infiltrates and epithelial cells. Clin Immunol. 2017,182: 30-40[2017-12-05]. https;//linkinghub. elsevier. com/retrieve/pii/S1521-6616 ( 16 ) 30696-9. doi: 10. 1016/j. dim. 2017.03.007.

PHENEKOSC, VRYONIDOU A, GRITZAPIS AD. et al. ТЫ and Th2 serum cytokine profiles characterize patients with Hashimoto’ s thyroiditis ( Thl ) and Graves ’ disease ( Th2). Neuroimmunodulation. 2004 ,11(4): 209-213.

MALIKA M, AHMED AR. Concurrence of systemic lupus erythematosus and pemphigus; coincidence or correlation,Dermatology,2007, 214 (3): 231-239.

Posselt RT, Coelho VN, Skare TL. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus. Int J Rheum Dis, 2017, 25 [2017-12-05]. https://www. ncbi. nlm. nih. gov/pubmed/28544477. doi; 10. 1111/1756-185X. 13089.

SEYFERTS, KLAPPS P. MEISEL G, et al. Multiple sclerosis and other immunologic diseases. Acta Neuro Scand. 1990,81(l):37-42.

MCDONAGH JE, ISENBERG DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis,2000, 59(3):230-232.

BARTALENA L, M ARCOCCI С, TANDA ML, et al. An update on medical management of Graves’ ophthalmopathy. J Endocrinol Invest,2005,28(5);469-478.

HOZUNI Y, KOBAYASHI E, MIYATA M, et al. Immunotherapy for experimental rat autoimmune thyroiditis using a novelimmunosuppressant, FTY720. Life Sci, 1999,65 (17):1739-1745.

LIU Y. CHEN S, SUN Y. et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease. Medicine ( Baltimore), 2016 ,95 ( 50): e5565[2017-11- 07]. https: / / www. ncbi. nlm. nih. gov/pmc/articles/ РМС5268034/. doi: 10. 1097/MD. 0000000000005565.

VALIM V, GERDTS E, JONSSON R, et al. Atherosclerosis in Sjogren ’ s syndrome; evidence, possible mechanisms and knowledge gaps. Clin Exp Rheumatol,2016 . 34(1);133-142.

PIESK T, KOTIMOK J, MONNIKK M. et al. Concomitant diseases and their effect on disease prognosis in Meniere9 jv, disease: diabetes mellitus identified as a negative prognostic factor. Acta Otolaryngol, 2017, 15: 1-5 [ 2017-11-07 ]. https://www. ncbi. nlm. nih. gov/pubmed/28914106. doi: 10. 1080/00016489. 2017. 1373850.


Refbacks

  • There are currently no refbacks.